Table of Contents: Preface
1. Emotional Memory in Alzheimer¡¯s Disease
(Jill D. Waring and Elizabeth A. Kensinger, Department of Psychology, Boston College, Chestnut Hill, MA USA) pp.9-36
2. Mechanisms of Amyloid-B Clearance in Alzeheimer's Disease
(Joseph El Khoury, Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology and Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, and Suzanne E. Hickman, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA)pp.37-66
3. Synaptic transmission regulates amyloid-¦Â dynamics
(John R. Cirrito, Department of Neurology, Washington University School of Medicine, St. Louis, MO)pp.67-84
4. Anti-AB Antibodies For the Treatment of Alzheimer's Disease
(Bin Liu*, Hongjun Fu*, Jeffrey L. Frost, and Cynthia A. Lemere Center for Neurologic Disease, Brigham & Women¡¯s Hospital and Harvard Medical School, Boston, MA)pp.85-112
5. The Failure of the APP Transgenic Mouse Models to Predict Efficacy of Agents in Five Clinical Trials of Alzheimer¡¯s Disease Suggests That There is a Need for a New Paradigm for Drug Development.
(Jordan L. Holtzman, University of Minnesota, Minneapolis, MN)pp.113-144
6. Apolipoprotein E and Alzheimer¡¯s Disease: An Update on Allele-Specific Effects of Disease Etiology
(Ann M. Saunders, Genetics Research GlaxoSmithKline R&D
Research Triangle Park, NC)pp.145-160
7. Chronic Inflammation and Alzheimer¡¯s Disease
(Douglas G. Walker, Jason Yuan and Lih-Fen Lue, Sun Health Research Institute, Sun City, AZ)pp.161-184
8. Cathepsins in Alzheimer¡¯s disease and dementia: Cathepsin inhibitors as potential anti-dementic therapeutics
(Azizul Haque, Naren L. Banik1,and Swapan K. Ray, Medical University of South Carolina, Charleston, SC and University of South Carolina School of Medicine, Columbia, SC)pp.185-198
9. Role of gelsolin in Alzheimer¡¯s disease
(Lina Ji, Abha Chauhan, Ved Chauhan, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY)pp.199-218
10. Declarative memory impairment and hippocampal atrophy in Parkinson¡¯s disease
(Carme Junque, Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Spain)pp.219-242
11. Fronto-temporal dementia
(Alfredo Postiglione, Graziella Milan and Sabina Pappat¨¤, University of Naples, Naples, Italy and Institute of Biostructures & Bioimaging, CNR, Naples, Italy)pp.243-262
12. Cognitive impairment in schizophrenia
(Verity C Leeson and Eileen M Joyce, UCL Institute of Neurology, Queen Square, London) pp.263-280
Index pp.281-306 |